76 related articles for article (PubMed ID: 1689897)
1. Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings.
Transplant Proc; 1990 Feb; 22(1):5-113. PubMed ID: 1689897
[No Abstract] [Full Text] [Related]
2. First International Workshop on FK-506. A potential breakthrough in immunosuppression. Proceedings.
Starzl TE
Transplant Proc; 1987 Oct; 19(5 Suppl 6):1-104. PubMed ID: 2445066
[No Abstract] [Full Text] [Related]
3. Effect of splenectomy in combination with FK 506 and 15-deoxyspergualin on cardiac xenograft survival.
Carobbi A; Araneda D; Patselas T; Thomas J; Mosca F; Thomas F
Transplant Proc; 1991 Feb; 23(1 Pt 1):549-50. PubMed ID: 1703704
[No Abstract] [Full Text] [Related]
4. International Symposium on Immunosuppression in Renal Transplantation. October 5-6, 1987, Barcelona, Spain. Proceedings.
Transplant Proc; 1988 Oct; 20(5 Suppl 6):1-103. PubMed ID: 3051576
[No Abstract] [Full Text] [Related]
5. Donor bone marrow cell facilitates induction of tolerance to kidney allografts in dogs treated with fractionated lymphoid irradiation and FK 506.
Watanabe K; Yuge K; Sato K; Sonoda K; Masaki Y; Maruyama S; Okubo M; Obata F; Otani F; Kaneko T
Transplant Proc; 1991 Feb; 23(1 Pt 1):568-72. PubMed ID: 1703706
[No Abstract] [Full Text] [Related]
6. Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.
Starzl TE; Abu-Elmagd K; Tzakis A; Fung JJ; Porter KA; Todo S
Transplant Proc; 1991 Feb; 23(1 Pt 2):914-9. PubMed ID: 1703351
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of tolerance induced by a perioperative injection of bone marrow cells and a brief course of FK 506.
Ito T; Nakata S; Shirakura R; Yamamoto S; Miyata M; Kawashima Y
Transplant Proc; 1991 Feb; 23(1 Pt 1):844-6. PubMed ID: 1703716
[No Abstract] [Full Text] [Related]
8. Clinical use of FK 506 in liver transplantation.
Klintmalm GB
Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
[TBL] [Abstract][Full Text] [Related]
9. [Histological observations of immunosuppressive effects of FK-506 in canine lung allotransplantation].
Aoki M; Hitomi S; Wada H; Inui K; Yamazaki F; Yokomise H; Lee M; Hirai T; Hasegawa S
Bull Chest Dis Res Inst Kyoto Univ; 1989 Mar; 22(1-2):65-72. PubMed ID: 2482787
[TBL] [Abstract][Full Text] [Related]
10. The influence of FK 506 on the thymus: implications of drug-induced injury to thymic epithelial cells.
Thomson AW; Pugh-Humphreys RG; Woo J
Transplant Proc; 1991 Feb; 23(1 Pt 2):947-8. PubMed ID: 1703361
[No Abstract] [Full Text] [Related]
11. [FK-506. A new immunosuppressive drug].
MacLeod AM; Thomson AW
Medicina (Firenze); 1990; 10(3):329-32. PubMed ID: 1706817
[TBL] [Abstract][Full Text] [Related]
12. Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.
Morris RE; Meiser BM; Wu J; Shorthouse R; Wang J
Transplant Proc; 1991 Feb; 23(1 Pt 1):521-4. PubMed ID: 1703698
[No Abstract] [Full Text] [Related]
13. One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.
Todo S; Fung JJ; Tzakis A; Demetris AJ; Jain A; Alessiani M; Takaya S; Day R; Gordon R; Starzl TE
Transplant Proc; 1991 Feb; 23(1 Pt 2):1397-402. PubMed ID: 1703340
[TBL] [Abstract][Full Text] [Related]
14. FK 506-based immunosuppression in clinical pancreas transplantation.
Swanson C; Rubin M; Colquhoun S; Basadonna G; Asshinnik A; Perez R
Transplant Proc; 1995 Dec; 27(6):3031. PubMed ID: 8539827
[No Abstract] [Full Text] [Related]
15. Immunosuppression. Binding by design.
Ringe D
Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317
[No Abstract] [Full Text] [Related]
16. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.
Walliser P; Benzie CR; Kay JE
Immunology; 1989 Nov; 68(3):434-5. PubMed ID: 2480331
[TBL] [Abstract][Full Text] [Related]
18. FK 506--an investigational immunosuppressant.
Med Lett Drugs Ther; 1991 Oct; 33(854):94. PubMed ID: 1716722
[No Abstract] [Full Text] [Related]
19. Immunosuppression. Convergence of drug action.
Freedman RB
Nature; 1989 Oct; 341(6244):692. PubMed ID: 2477712
[No Abstract] [Full Text] [Related]
20. Measurement of FK 506 by HPLC and isolation and characterization of its metabolites.
Christians U; Kruse C; Kownatzki R; Schiebel HM; Schwinzer R; Sattler M; Schottmann R; Linck A; Almeida VM; Braun F
Transplant Proc; 1991 Feb; 23(1 Pt 2):940-1. PubMed ID: 1703358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
